Why Surgery Partners (SGRY) stock is trading up today

Surgery Partners (SGRY) stock rose 46.4% after HealthSpan Partners agreed to acquire it for $5.7B. Shareholders will receive $23.50 per share, a 49% premium. The deal is expected to close in Q1 2027, pending approvals. SGRY shares are up 51.6% YTD, hitting a 52-week high.

Original reporting
Published Oct 26, 2026, 5:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 6:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Surgery Partners (SGRY) stock is trading up today — source image
Decision brief

The 30-second read

$SGRYBullishHigh
01

Why it matters

The cash offer at $23.50 per share represents a 49% premium, prompting a 46.4% share surge and setting a new 52‑week high.

02

Market read

The deal is a material event for the healthcare sector, driving immediate price action and signaling continued consolidation.

03

What to watch

Potential integration costs and the $109 M termination fee may affect long‑term value beyond the premium.

Relevance 9/10Novelty 9/10Timing: intraday today

Background

Surgery Partners provides outpatient surgical facilities; the acquisition by HealthSpan Partners (Bon Secours Mercy Health affiliate) creates a larger integrated health platform.

Company-level read

Ticker impact

$SGRYBullishHigh confidence
Context

Shares jumped 46.4% after HealthSpan Partners announced a $23.50 cash‑per‑share acquisition valued at $5.7 B.

Expected impact

upward pressure as the deal closes, with potential moderation after the initial jump.

Evidence & confidence

The cash offer at a 49% premium is a material catalyst, and the trade is already reflected in the 46% intraday move.

Market effects

Consolidation in the outpatient surgery services sector may lift peers and increase M&A activity.

U.S. healthcare M&A sentiment improves, supporting related healthcare stocks.

Large‑cap healthcare deal highlights continued capital deployment in the sector worldwide.

Counterpoint

Deal risk (antitrust, financing) could cause a pull‑back if approvals stall, making the post‑jump price vulnerable.

Key entities

  • Surgery Partners

    Target of the acquisition, ticker SGRY.

  • HealthSpan Partners

    Acquirer, affiliate of Bon Secours Mercy Health.

Related articles

$SGRYMed

Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032 BRENTWOOD, Tenn., November 16, 2026 – Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its in

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.